Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,776 | 116 | 82.6% |
| Travel and Lodging | $328.01 | 2 | 9.8% |
| Education | $257.03 | 7 | 7.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $621.36 | 21 | $0 (2024) |
| Intuitive Surgical, Inc. | $472.05 | 3 | $0 (2023) |
| NeoTract Inc. | $231.63 | 1 | $0 (2017) |
| ABBVIE INC. | $231.01 | 13 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $160.06 | 6 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $148.19 | 6 | $0 (2023) |
| Merck Sharp & Dohme LLC | $131.35 | 5 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $116.11 | 7 | $0 (2024) |
| ACCORD HEALTHCARE, INC. | $107.18 | 5 | $0 (2024) |
| PFIZER INC. | $96.09 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $922.59 | 45 | ABBVIE INC. ($162.28) |
| 2023 | $1,497 | 44 | Intuitive Surgical, Inc. ($472.05) |
| 2022 | $201.55 | 7 | Astellas Pharma US Inc ($99.99) |
| 2020 | $314.20 | 17 | Astellas Pharma US Inc ($91.93) |
| 2019 | $164.30 | 9 | Astellas Pharma US Inc ($37.46) |
| 2018 | $29.36 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($17.49) |
| 2017 | $231.63 | 1 | NeoTract Inc. ($231.63) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: HORMONE THERAPY | ||||||
| 10/18/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Oncology | ||||||
| 09/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/24/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $26.61 | General |
| Category: HORMONE THERAPY | ||||||
| 09/17/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: Oncology | ||||||
| 09/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Prostate cancer | ||||||
| 08/08/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $41.55 | General |
| Category: Urology | ||||||
| 07/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: rezum_URO | ||||||
| 06/24/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: HORMONE THERAPY | ||||||
| 06/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Oncology | ||||||
| 05/22/2024 | 180 Medical, Inc. | CURE CATHETER (Device) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: CONTINENCE CARE | ||||||
| 05/17/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: ONCOLOGY | ||||||
| 05/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: ONCOLOGY | ||||||
| 05/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/30/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $14.11 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,889 | 2,361 | $496,521 | $125,858 |
| 2022 | 23 | 1,788 | 2,431 | $452,265 | $116,235 |
| 2021 | 26 | 1,914 | 4,252 | $410,324 | $114,797 |
| 2020 | 21 | 1,221 | 1,666 | $253,153 | $67,791 |
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 270 | 390 | $126,750 | $34,518 | 27.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 105 | 114 | $72,162 | $19,580 | 27.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 156 | 156 | $66,144 | $17,779 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 204 | $47,124 | $12,338 | 26.2% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 13 | 13 | $28,600 | $6,695 | 23.4% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 18 | 19 | $26,400 | $6,361 | 24.1% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 16 | 17 | $14,127 | $4,174 | 29.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 23 | 23 | $14,375 | $4,059 | 28.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 301 | 435 | $23,925 | $3,201 | 13.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 23 | 25 | $13,600 | $2,910 | 21.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $7,797 | $2,289 | 29.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 21 | 21 | $11,109 | $2,228 | 20.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 51 | 53 | $7,632 | $2,083 | 27.3% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 329 | 440 | $11,000 | $1,728 | 15.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 23 | 23 | $6,555 | $1,634 | 24.9% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 22 | 29 | $5,800 | $1,326 | 22.9% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 117 | 141 | $4,935 | $1,109 | 22.5% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 53 | 66 | $2,640 | $551.43 | 20.9% |
| 87088 | Bacterial urine culture | Office | 2023 | 55 | 69 | $2,415 | $540.51 | 22.4% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 54 | 67 | $2,345 | $525.14 | 22.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 19 | $988.00 | $203.40 | 20.6% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 14 | 14 | $98.00 | $29.24 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 216 | 289 | $93,925 | $26,674 | 28.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 235 | 300 | $69,300 | $18,398 | 26.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 76 | 86 | $54,438 | $15,456 | 28.4% |
About Dr. Philip Rosen, MD
Dr. Philip Rosen, MD is a Urology healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2008. The National Provider Identifier (NPI) number assigned to this provider is 1194986026.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Rosen, MD has received a total of $3,361 in payments from pharmaceutical and medical device companies, with $922.59 received in 2024. These payments were reported across 125 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($2,776).
As a Medicare-enrolled provider, Rosen has provided services to 6,812 Medicare beneficiaries, totaling 10,710 services with total Medicare billing of $424,681. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology, Urology
- Location Salem, OR
- Active Since 06/23/2008
- Last Updated 07/23/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1194986026
Products in Payments
- Da Vinci Surgical System (Device) $472.05
- Myrbetriq (Drug) $269.96
- Urolift - UL400 (Device) $231.63
- BOTOX (Biological) $196.62
- PROVENGE (Drug) $148.19
- XTANDI (Drug) $140.43
- KEYTRUDA (Biological) $131.35
- ORGOVYX (Drug) $130.35
- CAMCEVI (Drug) $107.18
- PROLARIS (Device) $94.75
- ELIGARD (Drug) $94.17
- MYRBETRIQ (Drug) $73.18
- XGEVA (Biological) $72.51
- YONSA (Drug) $69.04
- ADSTILADRIN (Biological) $68.79
- Trelstar (Drug) $60.26
- LYNPARZA (Drug) $59.37
- CURE CATHETER (Device) $57.18
- ERLEADA (Drug) $57.17
- SPEEDICATH (Device) $51.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Salem
Dr. Mark Laspina, D.o, D.O
Urology — Payments: $19,777
Stuart Diamond, Md, MD
Urology — Payments: $18,471
Dr. Alejandra Balen, M.d, M.D
Urology — Payments: $14,486
Bradley Warner, M.d, M.D
Urology — Payments: $10,038
Mr. Noel Defelippo, Md, MD
Urology — Payments: $8,224
Dr. John Mhoon, M.d, M.D
Urology — Payments: $7,907